- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x UK9: 7,8-bis(oxidanyl)-2-phenyl-chromen-4-one(Non-covalent)
UK9.2: 12 residues within 4Å:- Chain A: D.27, N.60, S.61, R.62, G.115, Y.150, E.152, H.182, P.183, L.184, T.190
- Ligands: GOL.3
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:R.62, A:Y.150, A:H.182
- Hydrogen bonds: A:S.61, A:S.61, A:R.62, A:E.152
- Water bridges: A:R.62, A:T.193
- pi-Stacking: A:Y.150, A:Y.150
UK9.7: 12 residues within 4Å:- Chain B: D.27, N.60, S.61, R.62, G.115, Y.150, E.152, H.182, P.183, L.184, T.190
- Ligands: GOL.8
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:R.62, B:Y.150, B:H.182
- Hydrogen bonds: B:S.61, B:S.61, B:R.62, B:E.152
- Water bridges: B:R.62, B:E.152, B:T.193
- pi-Stacking: B:Y.150, B:Y.150
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 9 residues within 4Å:- Chain A: D.27, W.31, G.33, E.34, N.60, R.62, R.63, R.71
- Ligands: UK9.2
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:D.27, A:W.31, A:G.33, A:E.34, A:N.60, A:R.62, A:R.63, A:R.63, A:R.71
GOL.8: 9 residues within 4Å:- Chain B: D.27, W.31, G.33, E.34, N.60, R.62, R.63, R.71
- Ligands: UK9.7
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:D.27, B:W.31, B:G.33, B:E.34, B:N.60, B:R.62, B:R.63, B:R.63, B:R.71
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.4: 8 residues within 4Å:- Chain A: D.25, C.26, D.27, S.58, N.59, N.60, K.213
- Ligands: MG.1
15 PLIP interactions:15 interactions with chain A- Hydrogen bonds: A:C.26, A:D.27, A:D.27, A:S.58, A:S.58, A:S.58, A:N.59, A:N.60
- Water bridges: A:N.59, A:H.182, A:K.213, A:K.213, A:K.213, A:R.239
- Salt bridges: A:K.213
PO4.5: 6 residues within 4Å:- Chain A: R.65, E.83, F.86, R.94, N.225, F.226
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.225
- Salt bridges: A:R.65, A:R.94
PO4.9: 8 residues within 4Å:- Chain B: D.25, C.26, D.27, S.58, N.59, N.60, K.213
- Ligands: MG.6
15 PLIP interactions:15 interactions with chain B- Hydrogen bonds: B:C.26, B:D.27, B:S.58, B:S.58, B:S.58, B:N.59, B:N.60
- Water bridges: B:N.59, B:D.179, B:H.182, B:K.213, B:K.213, B:K.213, B:R.239
- Salt bridges: B:K.213
PO4.10: 6 residues within 4Å:- Chain B: R.65, E.83, F.86, R.94, N.225, F.226
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.225
- Salt bridges: B:R.65, B:R.94
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brenner, M. et al., 7,8-Dihydroxyflavone is a direct inhibitor of human and murine pyridoxal phosphatase. Elife (2024)
- Release Date
- 2024-06-12
- Peptides
- Chronophin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 2 x UK9: 7,8-bis(oxidanyl)-2-phenyl-chromen-4-one(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brenner, M. et al., 7,8-Dihydroxyflavone is a direct inhibitor of human and murine pyridoxal phosphatase. Elife (2024)
- Release Date
- 2024-06-12
- Peptides
- Chronophin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A